News Releases Home Synthetic Biology The History of Synthetic Biology Living Medicines Designing Synthetic Biotic™ Medicines Pipeline + Programs For Patients Our People Leadership Board of Directors Founders and Advisors Join Us Investors + Media Company Overview News & Events News Releases Event Calendar Presentations & Publications Stock Information Corporate Governance Financials Investor Resources Items Per Page 102550 Year None2020201920182017201620152014 December 12, 2018 Synlogic Expands Capabilities in Manufacturing with the Appointment of Head of Technical Operations and Establishment of In-house Production of Clinical Trial Material for its Synthetic BioticTM Medicines November 20, 2018 Synlogic to Webcast Presentation at the 30th Annual Piper Jaffray Healthcare Conference November 13, 2018 Synlogic Reports Third Quarter 2018 Financial Results and Provides Program Updates November 12, 2018 Synlogic Presents Data at the 2018 Liver Meeting, the Annual Meeting of the American Association for the Study of Liver Disease (AASLD) November 7, 2018 Synlogic Announces Third Quarter 2018 Conference Call and Webcast November 6, 2018 Synlogic Presents Preclinical Data from First Synthetic BioticTM Clinical Candidate in Immuno-Oncology at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting November 1, 2018 Synlogic to Host Analyst & Investor Event at the Society for Immunotherapy of Cancer (SITC) 2018 Annual Meeting October 2, 2018 Synlogic Appoints Dr. Aoife Brennan as President and Chief Executive Officer September 25, 2018 Synlogic to Webcast Presentation at the Leerink Partners Roundtable Series: Rare Disease & Oncology September 4, 2018 Synlogic Reports Positive Interim Phase 1/2a Data Demonstrating Safety, Tolerability and Proof-of-Mechanism in Healthy Volunteers for SYNB1618, in Development for the Management of Phenylketonuria (PKU) Pagination First page « first Previous page ‹ previous Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last » Displaying 31 - 40 of 97 Email Alerts Contact IR RSS Feeds Print Page Email Page
Items Per Page 102550 Year None2020201920182017201620152014 December 12, 2018 Synlogic Expands Capabilities in Manufacturing with the Appointment of Head of Technical Operations and Establishment of In-house Production of Clinical Trial Material for its Synthetic BioticTM Medicines November 20, 2018 Synlogic to Webcast Presentation at the 30th Annual Piper Jaffray Healthcare Conference November 13, 2018 Synlogic Reports Third Quarter 2018 Financial Results and Provides Program Updates November 12, 2018 Synlogic Presents Data at the 2018 Liver Meeting, the Annual Meeting of the American Association for the Study of Liver Disease (AASLD) November 7, 2018 Synlogic Announces Third Quarter 2018 Conference Call and Webcast November 6, 2018 Synlogic Presents Preclinical Data from First Synthetic BioticTM Clinical Candidate in Immuno-Oncology at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting November 1, 2018 Synlogic to Host Analyst & Investor Event at the Society for Immunotherapy of Cancer (SITC) 2018 Annual Meeting October 2, 2018 Synlogic Appoints Dr. Aoife Brennan as President and Chief Executive Officer September 25, 2018 Synlogic to Webcast Presentation at the Leerink Partners Roundtable Series: Rare Disease & Oncology September 4, 2018 Synlogic Reports Positive Interim Phase 1/2a Data Demonstrating Safety, Tolerability and Proof-of-Mechanism in Healthy Volunteers for SYNB1618, in Development for the Management of Phenylketonuria (PKU) Pagination First page « first Previous page ‹ previous Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last » Displaying 31 - 40 of 97
December 12, 2018 Synlogic Expands Capabilities in Manufacturing with the Appointment of Head of Technical Operations and Establishment of In-house Production of Clinical Trial Material for its Synthetic BioticTM Medicines
November 20, 2018 Synlogic to Webcast Presentation at the 30th Annual Piper Jaffray Healthcare Conference
November 12, 2018 Synlogic Presents Data at the 2018 Liver Meeting, the Annual Meeting of the American Association for the Study of Liver Disease (AASLD)
November 6, 2018 Synlogic Presents Preclinical Data from First Synthetic BioticTM Clinical Candidate in Immuno-Oncology at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting
November 1, 2018 Synlogic to Host Analyst & Investor Event at the Society for Immunotherapy of Cancer (SITC) 2018 Annual Meeting
September 25, 2018 Synlogic to Webcast Presentation at the Leerink Partners Roundtable Series: Rare Disease & Oncology
September 4, 2018 Synlogic Reports Positive Interim Phase 1/2a Data Demonstrating Safety, Tolerability and Proof-of-Mechanism in Healthy Volunteers for SYNB1618, in Development for the Management of Phenylketonuria (PKU)